Common Contracts
2 similar Sales Agreement contracts by Dare Bioscience, Inc., Vaxart, Inc.
DARÉ BIOSCIENCE, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • March 31st, 2023 • Dare Bioscience, Inc. • Pharmaceutical preparations • New York
Daré Bioscience, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Stifel, Nicolaus & Company, Incorporated (“Stifel Nicolaus”) and Cantor Fitzgerald & Co. (“Cantor”; each individually an “Agent” and together, the “Agents”), as follows:
VAXART, INC. Shares of Common Stock ($0.0001 par value per share) SALES AGREEMENTSales Agreement • July 8th, 2020 • Vaxart, Inc. • Biological products, (no disgnostic substances) • New York
